Welab participates in a new…
In collaboration with 12 partners from 6countries, Welab Barcelona is establishing the Antivirus PandemicPreparedness EuropeAn pLatform (APPEAL), a European research…
In collaboration with 12 partners from 6countries, Welab Barcelona is establishing the Antivirus PandemicPreparedness EuropeAn pLatform (APPEAL), a European research…
Discovery of WLB-89462, a New Drug-like and Highly Selective σ2 Receptor Ligand with Neuroprotective Properties”, in the Journal of Medicinal…
Fundación Medina and WeLab Barcelona have signed a collaboration agreement that allows combining experience and resources for the discovery and…
Scientists from the Pathology and Experimental Therapeutics Dept., Facultat de Medicina i Ciències de la Salut of the Universitat de…
We are proud to announce that Welab Barcelona, the drug discovery & development platform of Leitat, has signed a strategic…
Pharmacelera, the leading provider of computational tools for hit discovery, and Welab, the leading drug discovery and development platform is…
https://www.welabbarcelona.com/wp-content/uploads/2023/06/Welab-logo.mp4
WeLab Barcelona has reached an agreement with Spirify Pharma for a research collaboration on characterization of Spirify’s proprietary analogs of…
Check out the new Welab’s publication on toxicological profile of cizolirtine. Results from two-year rodent oral carcinogenicity studies of cizolirtine,…
Welab Barcelona is a Spanish leading platform for Drug Discovery and Development. Our goal is to be your partner in creating the next generation of tomorrow’s medicines
Dear colleagues, collaborators, and friends,
After more than 30 years of shared endeavours, in which we have grown personally and professionally, and with our emotions on the surface, we announce the closure of our company. We have travelled together through ups and downs, celebrated successes and overcome challenges as a team.
We extend our deepest gratitude to each of you for your dedication, passion, and commitment to a shared goal: discovering new treatments for the benefit and well-being of patients.
As we bid farewell, let’s cherish the memories we’ve created, the bonds we’ve formed, and the impact we’ve made together. Though our paths may diverge, the spirit of collaboration and camaraderie that defines our community will always endure.
We leave proud of the work accomplished and thank you for being an integral part of our journey, wishing you success in all your future challenges.
With heartfelt appreciation,
Welab’s team
We are proud to announce that Welab is partner of this new EU funded project.
In collaboration with 12 partners from 6 countries, Welab Barcelona is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics. This EU funded collaboration will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year time frame ensuring drug affordability and accessibility to low income countries.
Link to the press release: https://lnkd.in/d-jmV2CS